Platelet indices significantly correlate with liver fibrosis in HCV-infected patients.

Platelet indices significantly correlate with liver fibrosis in HCV-infected patients.

AIM:A total of 241 patients with chronic HCV infection were recruited to investigate the association between liver fibrosis and PLT counts, as well as with MPV, PDW and P-LCR indices. METHODS:The determination of PLT indices was carried out using a Sysmex XT-1800i automated hematology analyzer. Sero...

Full description

Bibliographic Details
Main Authors:	Lin-Nan Shao, Shu-Ting Zhang, Ni Wang, Wei-Jian Yu, Mei Chen, Nan Xiao, Ying Duan, Ling-Zi Pan, Wen-Qian Song, Yue-Xin Xia, Li Zhang, Ning Qi, Ming Liu, Shi-Hang Zhou
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0227544

Similar Items

β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development
by: Yue-Ming Ling, et al.
Published: (2017-10-01)

Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients
by: Valentina Li Vecchi, et al.
Published: (2013-09-01)

Anti-HCV DAA are needed whatever liver fibrosis is. The cons
by: Pablo Barreiro
Published: (2016-05-01)

Novel biomarkers assist in detection of liver fibrosis in HCV patients
by: Tamer A. Addissouky, et al.
Published: (2021-11-01)

Anti-HCV DAA are needed whatever liver fibrosis is. The pros
by: Albert Tran
Published: (2016-05-01)

Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection
by: Yi-Ning Dai, et al.
Published: (2023-09-01)

Non-invasive methods for the diagnosis of liver fibrosis in chronic HCV-infection
by: A. I. Fazul’zyanova, et al.
Published: (2021-03-01)

Evaluation of HCV-related liver fibrosis post-successful DAA therapy
by: Nermine Ehsan, et al.
Published: (2021-06-01)

Diagnostic Value of Serum Markers of Liver Fibrosis in Patients with HCV-Infection
by: S.L. Melanich
Published: (2013-11-01)

Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
by: Martina Casari, et al.
Published: (2023-12-01)

Detection rate of specific antibodies to the HCV CORE+1 protein in “naive” cronically HCV-infected patients in depends on the stage of liver fibrosis and the HCV subtype
by: E. V. Lichnaya, et al.
Published: (2021-01-01)

P-8 EXTRACELLULAR VESICLE-DERIVED MICRORNA SIGNATURE IN HCV AND HCV/HIV PATIENTS WITH DIFFERENT STAGES OF LIVER FIBROSIS
by: Victoria Cairoli, et al.
Published: (2023-03-01)

HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.
by: Florence Abravanel, et al.
Published: (2012-01-01)

Decreased in Liver Fibrosis in Patients with HCV/HIV Coinfection After Treatment with Sofosbuvir/Daclatasvir
by: Andreas Jonathan, et al.
Published: (2020-07-01)

Perivenular fibrosis in chronic HCV hepatitis.
by: Kennedy, M, et al.
Published: (1999)

Perivenular fibrosis in chronic HCV hepatitis.
by: Kennedy, M, et al.
Published: (1998)

Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients
by: Martina Gambato, et al.
Published: (2023-08-01)

Dynamic Changes in Non-Invasive Markers of Liver Fibrosis Are Predictors of Liver Events after SVR in HCV Patients
by: Paula Fernández-Alvarez, et al.
Published: (2023-05-01)

NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS USING LIVER ELASTOGRAPHY (FIBROSCAN) IN PATIENTS WITH CHRONIC INFECTION HBV AND HCV
by: Andreea Rădășan, et al.
Published: (2016-09-01)

Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community
by: Wei-Ming Chen, et al.
Published: (2021-05-01)

The largest American study comparing transient elastography and the aminotransferase-to-platelet ratio index score, two noninvasive tests for liver fibrosis staging in HIV/HCV coinfected patients
by: Jason Dazley, et al.
Published: (2019-01-01)

SIGNIFICANCE OF IMMUNOSUPPRESSION AND ELASTOMETRY INDICES OF LIVER IN THE TACTICS OF HIV/HCV CO-INFECTION TREATMENT
by: E.R. RAKHMANOV, et al.
Published: (2017-09-01)

Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents
by: Naim Abu-Freha, et al.
Published: (2023-09-01)

Diagnostic Accuracy of Serum Hyaluronan for Detecting HCV Infection and Liver Fibrosis in Asymptomatic Blood Donors
by: Itatiana F. Rodart, et al.
Published: (2021-06-01)

Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents
by: Hae Won Yoo, et al.
Published: (2022-01-01)

Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradicationKey points
by: Pierre Nahon, et al.
Published: (2019-12-01)

Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters
by: Joana Ferreira, et al.
Published: (2024-02-01)

Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.
by: Charlotte Charpentier, et al.
Published: (2013-01-01)

The Predictive Value of Mean Platelet Volume for Liver Fibrosis in Children With Chronic Liver Diseases
by: Seyed Mohsen Dehghani, et al.
Published: (2020-12-01)

No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients
by: Julio Collazos, et al.
Published: (2024-03-01)

Human platelets antigens influence the viral load of platelets after the interaction of the platelets with HCV and HIV in vitro
by: Rejane Maria Tommasini Grotto, et al.

AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis
by: Aurora Loaeza-del-Castillo, et al.
Published: (2008-10-01)

HCV and Oxidative Stress in the Liver
by: Sergey N. Kochetkov, et al.
Published: (2013-01-01)

Prevalence and Prognostic Significance of Liver Fibrosis in Patients With Aneurysmal Subarachnoid Hemorrhage
by: Tiangui Li, et al.
Published: (2022-06-01)

Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
by: I. A. Goncharova, et al.
Published: (2023-03-01)

PROGRESSION OF LIVER FIBROSIS IN MONOINFECTED PATIENTS BY HEPATITIS C VIRUS AND COINFECTED BY HCV AND HUMAN IMMUNODEFICIENCY VIRUS
by: Cristiane Valle TOVO, et al.
Published: (2013-03-01)

Expression of Inhibitory Receptors on T and NK Cells Defines Immunological Phenotypes of HCV Patients with Advanced Liver Fibrosis
by: Chisom Ifeoma Adaeze Okwor, et al.
Published: (2020-09-01)

Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy.
by: Nieves Embade, et al.
Published: (2016-01-01)

Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors
by: Patrizia Carrieri, et al.
Published: (2022-06-01)

Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma
by: Mona M Zoheiry, et al.
Published: (2015-12-01)